VC firms
European life sciences VC fund investing €53M in early-stage biotech. Supporting 20+ companies in drug discovery, medtech, diagnostics & AI.
Overview
Investment Stage
Pre-Seed; Seed; Series A
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 2, 2023 | Austrian biotech HeartBeat.bio secures €4.5M for cardioid drug discovery platform | Austrian biotech startup HeartBeat.bio has secured a € 4.5 million Pre-Series A round. The fresh capital will fuel the completion of its cardioid drug discovery platform for proprietary and collaborative drug discovery programs for the like... |
| May 12, 2023 | Dutch-based Delta Diagnostics secures €5.2M to commercialise its low-cost biosensing technology | Rotterdam-based Delta Diagnostics, a company that develops integrated photonics to create highly sensitive and selective biosensors, announced on Tuesday, May 9, that it has raised €5.25M in a Series A round of funding. The investment came ... |
| Nov 4, 2022 | i&i Biotech Fund investoval více než 1 milion eur do unikátní diagnostické technologie pro testování srážlivosti krve | Firma Enzyre je šestou společností, kterou pomohl fond i&i Biotech Fund od svého založení v srpnu 2021 svými investicemi podpořit. Více na www.inibio.eu. Jsme nadšeni, že můžeme společnost Enzyre doprovázet při vývoji tak slibné inovati... |
| Sep 27, 2022 | Nanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fund I | From left: M. Rodríguez Mariscal (Nanoligent), J. Zahrádka and B. Sumova (i&i Bio), M. Milos (Avanteca), M. Cano (Nanoligent), M. Marzola (IAG), R. Mangues (IIB S. Pau), P. Álamo (Nanoligent), A. Villaverde (IBB-UAB), I. Casanovas, L. A... |
| Sep 26, 2022 | Czech medtech company CasInvent Pharma raises €1.3M in a follow-up round | Czech medtech company CasInvent Pharma raises €1.3M in a follow-up round 26 September, 2022, 17:22 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> The Brno-based early-stage drug ... |
Reviews 0
FAQ about i&i Biotech Fund
What has the press written about i&i Biotech Fund?
Parsers VC has collected 6 articles mentioning i&i Biotech Fund, among them “Austrian biotech HeartBeat.bio secures €4.5M for cardioid drug discovery platform” (Nov 2, 2023) and “Dutch-based Delta Diagnostics secures €5.2M to commercialise its low-cost biosensing technology” (May 12, 2023).
Is i&i Biotech Fund still active?
Yes, i&i Biotech Fund is active; its latest activity on Parsers VC dates from Nov 3, 2023.